您的位置: 首页 > 农业专利 > 详情页

Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
专利权人:
Teva Pharmaceuticals International GmbH
发明人:
Michael Fetell,Richard Malamut,Michael J. Lamson,Ofer Spiegelstein,Yigal Paul Goldberg,Nicola Anne Price
申请号:
US15016921
公开号:
US09682033B2
申请日:
2016.02.05
申请国别(地区):
US
年份:
2017
代理人:
摘要:
Methods of treating postherpetic neuralgia in a mammal with a pharmaceutical composition comprising a spiro-oxindole compound of the formula:are disclosed. The methods provide excellent penetration of the spiro-oxindole compound into the affected skin area to effectively reduce the severity of the postherpetic neuralgia and/or to alleviate the postherpetic neuralgia with minimal or negligible systemic exposure of the spiro-oxindole compound.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充